WG
ESPR

Winton Group’s Esperion Therapeutics ESPR Stock Holding History

Winton Group’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.5K Sell
22,811
-35,534
-61% -$112K ﹤0.01% 1061
2025
Q4 		$216K Sell
58,345
-12,551
-18% -$40.6K 0.01% 820
2025
Q3 		$188K Buy
+70,896
New +$137K 0.01% 677
2021
Q2 		– Sell
-7,820
Closed -$219K – 1444
2021
Q1 		$219K Buy
+7,820
New +$231K 0.01% 1253
2018
Q4 		– Sell
-5,148
Closed -$228K – 916
2018
Q3 		$228K Sell
5,148
-2,665
-34% -$122K ﹤0.01% 922
2018
Q2 		$306K Buy
7,813
+66
+0.9% +$3.33K 0.01% 818
2018
Q1 		$560K Buy
+7,747
New +$569K 0.02% 723

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return